Page last updated: 2024-09-04

gadolinium dtpa and goralatide

gadolinium dtpa has been researched along with goralatide in 1 studies

Compound Research Comparison

Studies (gadolinium dtpa)	Trials (gadolinium dtpa)	Recent Studies (post-2010) (gadolinium dtpa)	Studies (goralatide)	Trials (goralatide)	Recent Studies (post-2010) (goralatide)
12,654	664	4,051	287	13	103

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chopp, M; Ding, G; Jiang, Q; Li, L; Li, Q; Wei, M; Zhang, L; Zhang, Z	1

Other Studies

1 other study(ies) available for gadolinium dtpa and goralatide

Article	Year
MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat. Neuroscience, 2014, Jun-20, Volume: 271 Topics: Acute Disease; Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Contrast Media; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Fibrinolytic Agents; Gadolinium DTPA; Immunohistochemistry; Infarction, Middle Cerebral Artery; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Oligopeptides; Rats, Wistar; Tissue Plasminogen Activator	2014

Article

Year

MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.

Neuroscience, 2014, Jun-20, Volume: 271

Topics: Acute Disease; Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Contrast Media; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Fibrinolytic Agents; Gadolinium DTPA; Immunohistochemistry; Infarction, Middle Cerebral Artery; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Oligopeptides; Rats, Wistar; Tissue Plasminogen Activator

2014